They found lower pain scores in participants treated with GLP-1RA, along with less cartilage damage and a reduced need for surgery
Recent studies have reported cases of semaglutide-associated hyposalivation (a type of GLP-1 RA), where patients experienced minimal salivation and xerostomia, which dissipated as soon as they discontinued taking the GLP-1 RA ( Mawardi et al
T cells that have been recruited to atherosclerotic plaques likely experience increased cell death, which may further stress efferocytes and contribute to an inflammatory microenvironment 87,88
Effectively proven
If you're unsure which supplement might best suit your needs, we encourage you to take our AI quiz
[3][4] For practitioners evaluating Retatrutide alternatives for weight loss, the primary approved options are Tirzepatide, an FDA-approved dual GLP-1/GIP receptor agonist (Mounjaro/Zepbound), and Semaglutide, an FDA-approved GLP-1 receptor agonist (Ozempic/Wegovy)